• Our Company
  • Our Mission & Commitment
  • Key Facts
  • Leadership
  • Governance
  • History
  • Compliance & Ethics
  • Diversity & Inclusion
  • Our Websites
  • Achievements
  • Business Information
• R&D
  • R&D Strategy
  • In the Pipeline
  • Investigational Compound News
  • Disease Areas of Focus
  • Our R&D
  • Our Science
  • R&D Highlights
  • Major R&D Facilities
  • Clinical Trials
  • Investigator- Sponsored Research
• Products
  • Help Paying For Your Medicine
  • Counterfeit Drugs
  • Medical Information Inquiries
• News
  • Press Releases
  • Publications
  • Media Library
  • Key Facts
  • Leadership
  • Financial Reporting
  • Features
  • Achievements
  • Media Contacts
  • Subscribe to e-mail alerts
• Investors
  • Key Facts
  • Stock Information
  • SEC Filings
  • Financial Reporting
  • Events & Presentations
  • Shareholder Services
  • Investor Contacts
• Partnering
  • Why Partner With Us?
  • Areas of Interest
  • Our Process
  • Our Partners
  • Partnering News
  • Partnering Contact
• Responsibility
  • Bristol-Myers Squibb Foundation
  • Sustainability
  • Help Paying For Your Medicine
  • Building Our Communities
  • Grants & Giving
  • Position on Key Issues
  • Transparency
  • Clinical Trials
  • Combating Counterfeit Drugs
  • Disaster Relief & Product Donations
  • Achievements
  • Access to Medicines
• Careers
  • Job Opportunities
  • Our Culture
  • Diversity & Inclusion
  • Developing Our People
  • University Recruitment
  • Achievements
  • Benefits
  • Apply Now

BMS.com Home » Products » Help Paying For Your Medicine » Help for Uninsured Patients

We may be able to provide free Bristol-Myers Squibb prescription medicines to eligible patients who cannot afford them due to financial hardship.

Medicine of Interest:

• ABILIFY® (aripiprazole)
• AVALIDE® (irbesartan hydrochlorothiazide)
• AVAPRO® (irbesartan)
• BARACLUDE® (entecavir)
• ERBITUX® (cetuximab)
• IXEMPRA® (ixabepilone)
• KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release)
• NULOJIX® (belatacept)
• ONGLYZA® (saxagliptin)
• ORENCIA® (abatacept)
• PLAVIX® (clopidogrel bisulfate)
• REYATAZ® (atazanavir sulfate)
• SPRYCEL® (dasatinib)
• SUSTIVA® (efavirenz)
• YERVOY™ (ipilimumab)

Please click on the product links to see the Full Prescribing Information including Boxed WARNINGS for ABILIFY®, BARACLUDE®, and NULOJIX®, Boxed WARNING for YERVOY™ regarding immune-mediated adverse reactions, Boxed WARNINGS for ERBITUX® regarding infusion reactions and cardiopulmonary arrest, and Boxed WARNINGS for AVAPRO® and AVALIDE® regarding use in pregnancy. As soon as pregnancy is detected, discontinue use of AVAPRO® or AVALIDE®.